SMShauna Munir

Shauna Munir

*This is an algorithmically generated author record based on publicly available information.

Shauna Munir has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The clinical relevance of sleep disturbance (“insomnia”) in patients with advanced cancer receiving palliative care: a scoping review

    by Shauna Munir, Eva Jones, Faith Precious Omeokwe, Andrew Neil Davies

    Purpose: Sleep disturbance (“insomnia”) is common in patients with advanced cancer receiving specialist palliative care. The aim of this scoping review was to determine the clinical relevance of sleep disturbance in this cohort of patients. Methods: Standard methodology was employed, and four databases were searched from inception (Medline, CINAHL, Embase, and APA PsycInfo). Hand searching of relevant sources was also undertaken. Included studies needed to have a sleep focus, and to utilise a validated sleep assessment tool (and/or objective measure of sleep quality). Results: Sixteen studies met the criteria for inclusion. The studies highlight that sleep disturbance is associated with a range of physical symptoms (e.g. fatigue, drowsiness), a variety of psychological problems (e.g. anxiety, depression), impaired quality of life, and reduced overall survival. Conclusion: Sleep disturbance is an “orphan” symptom, and the results of this scoping review suggest that it deserves much greater attention. Indeed, healthcare professionals should screen all palliative care patients for the problem and, when identified, perform a thorough assessment and initiate an appropriate treatment.


  • Pharmacological interventions for sleep disturbance (“insomnia”) in patients with advanced cancer receiving specialist palliative care: a scoping review

    by Suzanne Ryan, Shauna Munir, Andrew Davies

    Purpose Sleep disturbance (“insomnia”) is common in patients with advanced cancer receiving specialist palliative care. The aim of this scoping review was to determine the evidence for the various pharmacological interventions utilised for sleep disturbance in this cohort of patients. Methods Standard scoping review methodology was employed, and four databases were searched from inception (Medline, CINAHL, Embase, and the Cochrane Library). Hand searching of relevant sources was also undertaken. The search excluded non-English publications, and studies involving herbal remedies, and “complementary therapies”. Results Ten studies met the criteria for inclusion. The studies involved benzodiazepines (n = 5), “Z-drugs” (n = 2), melatonin (n = 2), antidepressants (n = 1), antipsychotics (n = 2), and dual orexin receptor antagonists (n = 1). Only three studies were randomised controlled trials, and only five of the studies used validated sleep assessment tools. The studies were mostly small in size (median – 47 patients). Conclusions This scoping review highlights that the evidence to support pharmacological interventions for sleep disturbance in patients with advanced cancer receiving specialist palliative care is extremely limited. Further research is required not only to assess efficacy, but also tolerability, given the side effect profile of these drugs (and the frailty of the patients).


  • Open Access

    Non-pharmacological interventions for sleep disturbance (“insomnia”) in patients with advanced cancer: a scoping review

    by Shauna Munir, Michael Connolly, Andrew Neil Davies

    Purpose: Sleep disturbances are a common yet overlooked symptom in patients with advanced cancer. Pharmacological interventions have been widely used to manage sleep disturbances; however, concerns related to their adverse effects have resulted in a need for alternative interventions. The purpose of this scoping review is to appraise the published literature on the non-pharmacological management of sleep disturbances in patients with advanced cancer. Methods: This scoping review was completed using the recommended methodological framework. An extensive literature search was completed using five electronic databases (Medline, CINAHL, Embase, APA PsycINFO, CENTRAL) and the Cochrane library. There were no restrictions applied to the search in relation to the years published. Only studies published in the English language were included. Results: We identified 9 studies published between 2010 and 2023 which focused on non-pharmacological management of sleep disturbances in patients with advanced cancer. Specific interventions included cognitive behavioural therapy, mindfulness-based therapies, bright light therapy, sleep hygiene, and other non-standard interventions. Improvements in sleep disturbance were noted in all studies, but only some studies showed statistical significance. Conclusion: This scoping review identified a relatively small number of relevant studies, involving a relatively small number of participants. Moreover, the studies involved very different interventions, with very different methodologies (including type/time of assessments). Thus, it is difficult to recommend any particular non-pharmacological intervention at this time. Nevertheless, non-pharmacological interventions undoubtedly have a role to play in the management of sleep disturbance in patients with advanced cancer.